Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen.
about
HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesHeterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsVaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys.Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens.Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutationThe influence of delivery vectors on HIV vaccine efficacyA structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins.Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239Non-human primate models for AIDS vaccine research.Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.In situ hybridization AT-tailing with catalyzed signal amplification for sensitive and specific in situ detection of human immunodeficiency virus-1 mRNA in formalin-fixed and paraffin-embedded tissues.Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS modelBroadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV ControllersLong-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodiesBreaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challengeSendai virus as a backbone for vaccines against RSV and other human paramyxovirusesImproved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibodyImpact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques.Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells.First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensRNA-based viral vectors.Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses.Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles.Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases.Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
P2860
Q26799624-59AB8BF9-FECB-4D0A-BEFC-D54FDDFACA7EQ28394899-E4589DE2-5892-4F0E-9605-5AA1EF79DE4FQ33724322-CCBFE87C-3980-4A56-A364-EC20EBFEC909Q33843258-675CCDF5-C034-4794-BD6C-25B59754D351Q33930406-A797BC5C-39E9-4C67-902F-62FDCAAB203FQ34077543-FAB192CE-102A-47EE-BE45-DDA383DB1CA9Q34243491-EF165C45-A1A3-4E3A-A86A-836CCF1A34B3Q34353521-0A106069-57D7-41BD-BF17-D61B5C8BC098Q34594890-791C2151-FEA5-4D5E-8151-A7539F6F6A08Q34651604-3F8412DB-9E3F-4C22-8B9B-80C2C8C6E5C3Q34715769-5C8EACC8-8565-4FEB-97FE-C38B79286972Q35665837-B2C72B59-694B-4062-B3D8-56A04AA0F890Q35749016-AF87DF6E-EE80-4633-9AFC-8217A4BA6C3DQ35803633-4260DEAB-0234-49E5-94A6-CE9C0A0FBA27Q35831895-61FF8341-26E7-47B1-8B8E-E3E46DC963DDQ35857531-0E708952-D207-4CE3-8B8C-7E68BFF7EA24Q36314997-CBB83F04-6776-46AD-99FE-6DFF3C528BD8Q36402663-45833BF0-ED62-48F6-93F6-3FB7CF9927E0Q36525047-391AD85E-5685-4848-9D05-4FDF10DB0936Q36537806-C7FB0903-1471-4859-AD2D-D376F20111B0Q36538907-35CB715E-E396-45F4-AFAF-1B201A45E2D1Q37118707-B22F299E-1279-4672-9F40-53525A146B06Q37191899-D6F272B5-E4B7-414C-A46E-E6589F7A60CEQ37333878-EE5A5F0D-5141-4C23-B668-1B1710DD3935Q37547813-F936E8DF-47DF-452D-809C-C75E6497FCE8Q37578465-E36954DC-9A7D-4237-A3FA-3865983AD7A7Q38266413-977FDFD1-F64D-4667-8171-495FB769DF53Q38619108-6520D11F-2287-45E6-8E42-9CA482BB3168Q39699309-EE9B7FEB-45FC-4635-A582-BC830C322486Q39748804-8EC4C493-424B-4B30-BC90-F562E68F845DQ40566666-E6758FC8-EA24-41BB-BD06-98DFEE313317Q42847157-5CB0BB51-084D-40A7-999A-159EBCE28114Q45363591-87ACA655-2F1A-421C-8146-AB9A7EC4DCCDQ56993265-26A003F4-D191-409F-9BA0-B8DA737EEE60
P2860
Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Rapid appearance of secondary ...... ai virus vector boost regimen.
@ast
Rapid appearance of secondary ...... ai virus vector boost regimen.
@en
type
label
Rapid appearance of secondary ...... ai virus vector boost regimen.
@ast
Rapid appearance of secondary ...... ai virus vector boost regimen.
@en
prefLabel
Rapid appearance of secondary ...... ai virus vector boost regimen.
@ast
Rapid appearance of secondary ...... ai virus vector boost regimen.
@en
P2093
P2860
P1433
P1476
Rapid appearance of secondary ...... ai virus vector boost regimen.
@en
P2093
P2860
P304
11891-11896
P356
10.1128/JVI.75.23.11891-11896.2001
P577
2001-12-01T00:00:00Z